focus -WSS

focus

author：focus 2025-10-04 11:57:22 - browse：3

Vials and packaging for Leqembi, a new Alzheimer's medication approved in the U.S., but not yet in Europe. Illustration: Alex Hogan/STAT; Photo: Eisai via AP

LONDON — Starting Sunday, Alzheimer’s specialists will gather for a major conference in Amsterdam, convening at a time when the field, depending on which expert you ask, has some rare momentum behind it, with new therapies starting to show benefits for patients.

But despite the hard-won victories, the arrival of the new therapies presents a new set of challenges in Europe as countries plan for their possible rollouts, scientists and doctors told STAT.

Health systems will have to adapt to diagnose people earlier and monitor them for side effects associated with the treatments. If their medicines win European approval, companies will have to strike reimbursement deals in all member states, a process that often leaves some countries waiting years for new drugs to become available. The hurdles mean the therapies will likely be offered only at certain centers initially, constraining how many patients have access to them, doctors from across Europe said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Abbott's new stent may help patients with peripheral artery disease

focus

explore

WSS

Abbott's new stent may help patients with peripheral artery disease

Boston hospital trains restaurant workers on naloxone for overdoses

Obesity drug from Roche shows promise in early study

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

PBM reform efforts get punted in Congress

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

explore

focus

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

He's a Nobel laureate. Critics say he was misleading on Covid

Continuity nursing helped my family in our darkest PICU moments

Hottest summer in 2,000 years puts focus on extreme heat, health

Novavax promises a turnaround & Lilly roils the obesity market

Community Health Systems hospitals under DOJ investigation

Cancer drug shortages should be causing more outrage

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

23andMe had bad news about my health. I wish a person had delivered it

STAT series 'Denied by AI' wins major journalism prizes

explore

Novo Nordisk testing Wegovy against alcohol

STAT readers on older presidents, polypills, Medicare, and more

STAT series 'Denied by AI' wins major journalism prizes

Oak Street deal isn't the answer to health care's woes

Obesity drugs seen as possible treatment for liver disease MASH

Alabama frozen embryo ruling has major implications for IVF clinics

focus

focus

explore

focus